"Nitrosourea Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds in which the core molecule is R-NO, where R is UREA.
| Descriptor ID |
D009607
|
| MeSH Number(s) |
D02.654.692 D02.948.594
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nitrosourea Compounds".
Below are MeSH descriptors whose meaning is more specific than "Nitrosourea Compounds".
This graph shows the total number of publications written about "Nitrosourea Compounds" by people in this website by year, and whether "Nitrosourea Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nitrosourea Compounds" by people in Profiles.
-
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. Neuro Oncol. 2017 02 01; 19(2):252-258.
-
Atl1 regulates choice between global genome and transcription-coupled repair of O(6)-alkylguanines. Mol Cell. 2012 Jul 13; 47(1):50-60.
-
Update: current management issues in malignant melanoma. Melanoma Res. 2005 Oct; 15(5):319-24.
-
Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Pediatr Neurosurg. 1996 Oct; 25(4):174-81.
-
Phase II studies of PCNU and bisantrene in advanced renal cell carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):331-2.
-
Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983 Aug; 14(2):202-15.
-
Regional blood flow in ethylnitrosourea-induced brain tumors. Ann Neurol. 1983 Aug; 14(2):189-201.
-
In vivo drug sensitivity assay of clonogenic human melanoma cells and correlation with treatment outcome. Cancer Res. 1983 Jul; 43(7):3434-40.
-
Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer. Am J Clin Oncol. 1983 Feb; 6(1):49-52.
-
Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea. Am J Clin Oncol. 1982 Aug; 5(4):421-7.